My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 597

    1.

    PAI-1 and functional blockade of SNAI1 in breast cancer cell migration.

    Fabre-Guillevin E, Malo M, Cartier-Michaud A, Peinado H, Moreno-Bueno G, Vallée B, Lawrence DA, Palacios J, Cano A, Barlovatz-Meimon G, Charrière-Bertrand C.

    Breast Cancer Res. 2008;10(6):R100. Epub 2008 Dec 3.PMID: 19055748 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer.

    Castelló R, Estellés A, Vázquez C, Falcó C, España F, Almenar SM, Fuster C, Aznar J.

    Clin Chem. 2002 Aug;48(8):1288-95.PMID: 12142386 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

    Hildenbrand R, Schaaf A.

    Int J Oncol. 2009 Jan;34(1):15-23.PMID: 19082473 [PubMed - indexed for MEDLINE]Related articles

    4.

    Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.

    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.

    Int J Mol Med. 2008 Feb;21(2):251-9.PMID: 18204793 [PubMed - indexed for MEDLINE]Related articles

    5.

    Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

    Scand J Gastroenterol. 2005 Jul;40(7):783-93.PMID: 16109653 [PubMed - indexed for MEDLINE]Related articles

    6.

    Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.

    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.

    Int J Oncol. 2006 Apr;28(4):807-14.PMID: 16525628 [PubMed - indexed for MEDLINE]Related articles

    7.

    Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.

    Martens JW, Sieuwerts AM, Bolt-deVries J, Bosma PT, Swiggers SJ, Klijn JG, Foekens JA.

    Thromb Haemost. 2003 Feb;89(2):393-404.PMID: 12574821 [PubMed - indexed for MEDLINE]Related articles

    8.

    Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.

    Whitley BR, Church FC.

    Int J Oncol. 2005 Sep;27(3):749-57.PMID: 16077925 [PubMed - indexed for MEDLINE]Related articles

    9.

    Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.

    Fisher JL, Field CL, Zhou H, Harris TL, Henderson MA, Choong PF.

    Breast Cancer Res Treat. 2000 May;61(1):1-12.PMID: 10930085 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.

    Leissner P, Verjat T, Bachelot T, Paye M, Krause A, Puisieux A, Mougin B.

    BMC Cancer. 2006 Aug 31;6:216.PMID: 16945123 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.

    Paciucci R, Vilá MR, Adell T, Díaz VM, Torà M, Nakamura T, Real FX.

    Am J Pathol. 1998 Jul;153(1):201-12.PMID: 9665481 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4.

    Byon CH, Hardy RW, Ren C, Ponnazhagan S, Welch DR, McDonald JM, Chen Y.

    Lab Invest. 2009 Nov;89(11):1221-8. Epub 2009 Sep 14.PMID: 19752858 [PubMed - indexed for MEDLINE]Related articles

    13.

    Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.

    Whitley BR, Beaulieu LM, Carter JC, Church FC.

    Gynecol Oncol. 2007 Feb;104(2):470-9. Epub 2006 Oct 30.PMID: 17070899 [PubMed - indexed for MEDLINE]Related articles

    14.

    Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.

    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.

    Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70.PMID: 15790903 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.

    Umeda T, Eguchi Y, Okino K, Kodama M, Hattori T.

    J Pathol. 1997 Dec;183(4):388-97.PMID: 9496254 [PubMed - indexed for MEDLINE]Related articles

    16.

    Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size.

    Weinmann M, Thews O, Schroeder T, Vaupel P.

    Br J Cancer. 2002 Apr 22;86(8):1355-61.PMID: 11953898 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Expression profiles of fibrinolytic components in nasal mucosa.

    Sejima T, Madoiwa S, Mimuro J, Sugo T, Ishida T, Ichimura K, Sakata Y.

    Histochem Cell Biol. 2004 Jul;122(1):61-73. Epub 2004 Jun 12.PMID: 15197554 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.

    Dong Z, Saliganan AD, Meng H, Nabha SM, Sabbota AL, Sheng S, Bonfil RD, Cher ML.

    Neoplasia. 2008 May;10(5):439-49.PMID: 18472961 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

    Chazaud B, Ricoux R, Christov C, Plonquet A, Gherardi RK, Barlovatz-Meimon G.

    Am J Pathol. 2002 Jan;160(1):237-46.PMID: 11786417 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

    Bryan L, Paugh BS, Kapitonov D, Wilczynska KM, Alvarez SM, Singh SK, Milstien S, Spiegel S, Kordula T.

    Mol Cancer Res. 2008 Sep;6(9):1469-77.PMID: 18819934 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk